Sage Rhino Capital’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$221K	Buy	11,948 +207	+2%	+$3.63K	0.04%	260
2025 Q4	$183K	Sell	11,741 -970	-8%	-$13.9K	0.03%	291
2025 Q3	$186K	Buy	12,711 +107	+0.8%	+$1.59K	0.04%	276
2025 Q2	$195K	Buy	12,604 +919	+8%	+$13.6K	0.04%	255
2025 Q1	$174K	Sell	11,685 -155	-1%	-$2.17K	0.04%	242
2024 Q4	$157K	Buy	11,840 +1,538	+15%	+$21.1K	0.03%	249
2024 Q3	$146K	Buy	+10,302	New	+$146K	0.03%	256
2024 Q2	–	Sell	-11,787	Closed	-$164K	–	265
2024 Q1	$164K	Buy	+11,787	New	+$171K	0.04%	215
2023 Q4	–	Sell	-11,751	Closed	-$182K	–	247
2023 Q3	$182K	Buy	11,751 +831	+8%	+$12.9K	0.05%	199
2023 Q2	$172K	Buy	10,920 +178	+2%	+$2.92K	0.05%	205
2023 Q1	$177K	Buy	+10,742	New	+$171K	0.05%	203